A consortium led by the
University of Catania will spearhead a pilot project to develop
a blood test that can provide an early diagnosis of colon cancer
through nanotechnology, officials said Wednesday.
The 42-month, six-million-euro project called UltraPlaCad
(Ultrasensitive Plasmonic Devices for early Cancer Diagnosis) is
financed under the European Commission's Horizon 2020 program,
which chose it along with eight others from among 462
applicants.
It will allow health care providers to bypass invasive and
painful colonoscopies and biopsies in screening for the second
most common and second deadliest tumour among both men and women
in Italy.
The pilot project led by Catania University involves three
Italian institutes as well as institutions and universities from
Austria, the Czech Republic, Finland, France, Germany, and
Holland.
.
ALL RIGHTS RESERVED © Copyright ANSA
